Mianserin Generics Uk (Mianserin Hydrochloride)

Mianserin works by blocking central α2‑adrenergic receptors, which increases the release of norepinephrine and serotonin. It also antagonises histamine H1 and serotonin 5‑HT2 receptors, contributing to its antidepressant and sedative effects.

The appropriate dose of Mianserin is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerability. Dosage adjustments are made according to therapeutic response and any adverse effects observed.

Safety data for Mianserin in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made in consultation with a healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mianserin differs from selective serotonin reuptake inhibitors (SSRIs) by acting as an antagonist at α2‑adrenergic, H1 and 5‑HT2 receptors rather than inhibiting serotonin reuptake. This mechanism can result in a more sedating profile, which may be advantageous for patients with insomnia but less suitable for those needing high alertness.

Mianserin tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency.

Mianserin is taken orally, usually as a tablet. Patients should swallow the tablet whole with a glass of water, preferably with food to minimise gastrointestinal discomfort, unless otherwise directed by their prescriber.

Serious adverse events include agranulocytosis, seizures, severe hypotension and cardiac arrhythmias. Patients should be monitored for signs of infection, unexplained fainting, seizure activity or irregular heartbeats, and seek immediate medical attention if such symptoms occur.

Mianserin is contraindicated in individuals with known hypersensitivity to the drug, those currently taking monoamine oxidase inhibitors, and patients with severe hepatic impairment. Caution is also advised for patients with a history of seizures, blood dyscrasias or uncontrolled cardiovascular disease.